Hasmukh Jain

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 92 citations · Full text

Insights into the mechanism of natural terpenoids as NF-kB inhibitors: an overview on their anticancer potential

Hasmukh Jain, Naveen Dhingra, Tamanna Narsinghani et al. · Experimental Oncology · 2016 · 43 citations

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

Prashant Tembhare, Harshini Sriram, Twinkle Khanka et al. · Journal for ImmunoTherapy of Cancer · 2020 · 41 citations · Full text

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment

Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik et al. · Cancer Medicine · 2020 · 39 citations · Full text

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia

Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde et al. · Oncotarget · 2018 · 34 citations · Full text